Live Quote · NASDAQCODXHealthcare· Biotechnology

Co-Diagnostics, Inc.

$2.99 2.92%($-0.09)
TickerSpark Score
53/100
Mixed
96
Valuation
20
Profitability
35
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CODX research report →

52-Week Range4% of range
Low
$1.26
Current
$2.99
High
$46.50
Company Overviewco-dx.com

About the company

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting.

CEO
Dwight Egan
IPO
2017
Employees
112
HQ
Salt Lake City, UT, US

Price Chart

-65.15% · this period
$37.80$19.54$1.29Jul 02Dec 31Jul 02
Valuation
Market Cap
$3.34M
P/E
-0.09
P/S
4.65
P/B
0.42
EV/EBITDA
0.06
Div Yield
0.00%
Profitability
Gross Margin
9.49%
Op Margin
-4447.41%
Net Margin
-6753.69%
ROE
-164.92%
ROIC
-170.99%
Growth & Income
Revenue
$622.49K · -84.10%
Net Income
$-46,895,936 · -24.59%
EPS
$-35.25 · 5.24%
Op Income
$-31,283,352
FCF YoY
0.22%
Performance & Tape
52W High
$46.50
52W Low
$1.26
50D MA
$3.52
200D MA
$6.04
Beta
2.85
Avg Volume
5.78M

Get TickerSpark's AI analysis on CODX

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
May 23, 26Egan Dwight Hother4,584
May 23, 26Egan Dwight Hsell1,633
May 23, 26Egan Dwight Hother4,584
May 23, 26Brown Brian Leeother3,750
May 23, 26Brown Brian Leesell1,350
May 23, 26Brown Brian Leeother3,750
May 23, 26Abbott Richard Davidother1,890
May 23, 26Abbott Richard Davidother1,890
May 23, 26Abbott Richard Davidsell680
May 23, 26Murphy Edward L.other1,695
Coverage · CODX

Our CODX coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on CODX yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate CODX report →
Internal Compare

Similar companies

Peers in the same neighborhood.